| Angel Zamora, SPEECH THERAPY | |
|
382 S Main St, Cheshire, CT 06410-1379 | |
| (203) 250-9663 | |
| (203) 699-9641 |
| Full Name | Angel Zamora |
|---|---|
| Gender | Male |
| Speciality | Speech-language Pathologist |
| Location | 382 S Main St, Cheshire, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598400210 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 6156 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Angel Zamora, SPEECH THERAPY 382 S Main St, Cheshire, CT 06410-1379 Ph: (203) 250-9663 | Angel Zamora, SPEECH THERAPY 382 S Main St, Cheshire, CT 06410-1379 Ph: (203) 250-9663 |
News Archive
New research from a team of scientists at the Centre for Research in Molecular Modeling, Department of Chemistry and Biochemistry, Concordia University in Canada, has aimed to determine the potential causes of anaphylaxis or allergic reactions reported in some individuals after receiving COVID-19 vaccines, including the mRNA vaccines by Pfizer-BioNTech and Moderna.
When combined with standard chemotherapy, an international Phase III trial has shown that the oral targeted therapy vandetanib improves progression-free survival for patients with advanced non-small cell lung cancer, according to research from The University of Texas M. D. Anderson Cancer Center.
A new microscopy method could enable scientists to generate snapshots of dozens of different biomolecules at once in a single human cell, a team from the Wyss Institute of Biologically Inspired Engineering at Harvard University reported Sunday in Nature Methods.
Exelixis, Inc. has submitted an investigational new drug application (IND) to the U.S. Food and Drug Administration (FDA) for XL999, a proprietary novel anticancer compound.
› Verified 6 days ago
Colleen A Canas, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 105 Mountain Rd, Cheshire, CT 06410 Phone: 203-213-1326 | |
Mrs. Megan Porto, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 382 S Main St, Cheshire, CT 06410 Phone: 203-250-9663 | |
Mikayla Macclain, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 382 S Main St, Cheshire, CT 06410 Phone: 203-250-9663 Fax: 203-699-9641 | |
Sara Barnick, SPEECH THERAPIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 382 S Main St, Cheshire, CT 06410 Phone: 203-250-9663 Fax: 203-699-9641 | |
Mrs. Colleen Cull, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 132 Elm St, Cheshire, CT 06410 Phone: 203-250-9663 | |
Hannah Wilson, SPEECH THERAPIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 382 S Main St, Cheshire, CT 06410 Phone: 203-250-9663 Fax: 203-699-9641 | |
Amanda Rodriguez, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 382 S Main St, Cheshire, CT 06410 Phone: 203-250-9663 |